A new smart ring is joining the hot wearable market. Movano announced they are one step closer to getting FDA clearances for their Movano Ring and other Movano devices.
The Pleasanton, CA-based company announced the success of its initial hypoxia study, conducted in partnership with UCSF (University of California, San Francisco). This study aimed to assess the accuracy of Movano Ring’s SpO2 and heart rate data.
Related Reading:
- 2022 Smart Rings: what, why, and who for?
- Movano Health introduces Evie: a smart ring specifically designed for Women
- Smartwatches may not be as efficient as thought before: Is a smart ring the solution to detecting Sleep Apnea?
- Google exploring a screenless smart band wearable with Edge AI capabilities
In comparing the accuracy of the Ring’s data with the reference devices, the Movano Ring resulted in a 2% margin of error, well below the FDA’s 4% requirement for SpO2.
In addition, the Ring also estimated heart rate with accuracy commensurate with the FDA’s standards.
Based on the positive results from this study, Movano plans to conduct a larger pivotal study for the FDA submission later this year.
The Movano smart ring measures heart rate, heart rate variability, sleep, respiration, temperature, blood oxygen, steps, and calories. 
According to the company, It can tell you why you slept the way you did and that your resting heart rate’s higher after a few glasses of wine.
The Ring also features a temperature sensor that will be helpful for users who are looking for fertility planning features.
The company has also been involved in some cutting-edge research.
The California-based startup Movano has produced what it says is the smallest-ever system-on-a-chip (SoC) for glucose and cuffless blood pressure monitoring systems.
According to a press release issued by the company in June this year, they have successfully validated the functionality of the proprietary and patented system-on-a-chip (SoC).
At 4 mm x 6.7 mm, the SoC combines multiple antennas and a variety of frequencies in the smallest ever radio frequency (RF)-enabled integrated circuit (IC) designed specifically for blood pressure or glucose monitoring systems.
Movano built the integrated sensor from the ground up to achieve an unprecedented level of precision in health monitoring and has invested four years into this novel non-invasive sensor technology.
Given the success of Oura Ring, it is no surprise that new and formidable competitors are entering the Smart Ring health tech space.
